CCL

Összesen 6 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM116424
Első szerző:Ádám Dorottya (molekuláris biológus)
Cím:The TRPM5 antagonist TPPO increases sebaceous lipogenesis and exerts pro-inflammatory effects via activation of Akt and p38 MAPK cascades / Ádám D., Arany J., Pető O., Tóth B. I., Zouboulis C. C., Oláh A.
Dátum:2023
ISSN:0022-202X 1523-1747
Megjegyzések:We have previously shown that transient receptor potential vanilloid (TRPV)-1, -3, and -4 ion channels are negative regulators of sebaceous lipogenesis. Moreover, the transient receptor potential melastatin 5 (TRPM5) was recently demonstrated to be expressed in human hair follicles, where its homeostatic activity appeared to promote the anagen phase (PMID: 33773986). Because the immunofluorescent images published in said article indicated that sebaceous glands also exhibited TRPM5 positivity, TRPM5 modulators administered with the intention of influencing hair growth may also have an unintended impact on sebaceous gland functions. Thus, we aimed to investigate the effects of TRPM5 modulators on human SZ95 sebocytes. SZ95 sebocytes were treated with TRPM5 modulators (activators: 2,5-dimethylpyrazine [DMP], 2-heptanone [HEP]; antagonist: triphenylphosphine oxide [TPPO]), and viability (MTT-assay), lipid synthesis (Nile Red labeling), gene expression (Q-PCR, western blot), mediator release (ELISA), as well as time-dependent activation of relevant second messenger pathways (phosphokinase array) were monitored. Expression of TRPM5 was knocked down by siRNA-transfection. Expression of TRPM5 was found to be around detection limit at the mRNA level, and western blotting did not produce bands at the predicted molecular weights either. Because siRNA-mediated silencing of TRPM5 failed to alter the intensity of the apparently nonspecific bands, we concluded that TRPM5 is most likely not expressed in human sebocytes. Furthermore, we found that the activators did not influence viability and lipid synthesis. Interestingly TPPO promoted sebaceous lipogenesis, and increased interleukin (IL)-6 expression and release. Phosphokinase array revealed the time-dependent activation of several kinase cascades in response to TPPO-treatment. Using pharmacological inhibitors, we could demonstrate that lipogenic effect of TPPO was mediated via the activation of the Akt1/2/3 and p38 MAPK. We concluded that the use of TPPO is likely to influence sebaceous gland biology via activating certain cellular off-targets.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idézhető absztrakt
folyóiratcikk
TRPM5
sebocyte
TPPO
acne
dry skin
Megjelenés:Journal Of Investigative Dermatology. - 143 : 11 (2023), p. S354. -
További szerzők:Arany József (1990-) (klinikai laboratóriumi kutató, vegyész) Pető O. Tóth István Balázs (1978-) (élettanász) Zouboulis, Christos C. (1960-) (bőrgyógyász) Oláh Attila (1984-) (élettanász)
Pályázati támogatás:EFOP-3.6.3-VEKOP-16-2017-00009
EFOP
EFOP-3.6.1-16-2016-00022
EFOP
134235
OTKA
ÚNKP-23-5-DE-477
Egyéb
János Bolyai Research Scholarship
MTA
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM106381
035-os BibID:(PMID)36502939 (WoS)000984536200001 (Scopus)85149686723
Első szerző:Alimohammadi, Shahrzad (Gyógyszerész)
Cím:TRPV4 activation increases the expression of CD207 (Langerin) of monocyte-derived Langerhans cells, without affecting their maturation / Alimohammadi Shahrzad, Pénzes Zsófia, Horváth Dorottya, Gyetvai Ágnes, Bácsi Attila, Kis Nikoletta Gréta, Németh Ákos, Arany József, Oláh Attila, Lisztes Erika, Tóth Balázs István, Bíró Tamás, Szöllősi Attila Gábor
Dátum:2023
ISSN:0022-202X 1523-1747
Megjegyzések:Langerhans cells (LCs) are the sole professional antigen-presenting cell normally found in the human epidermal compartment. Research into their physiological role is hindered by the fact that they are invariably activated during isolation from the skin. To overcome this challenge, we turned to a monocyte-derived LC model (moLC), which we characterized with RNASeq, and compared the transcriptome of moLCs to donor-matched immature dendritic cells. We found that moLCs express markers characteristic of LC2 cells, as well as transient receptor potential vanilloid 4 (TRPV4). TRPV4 is especially important in skin, as it has been linked to conservation of the skin barrier, immunological responses as well as acute and chronic itch, but we know little about its function on LCs. Our results show that TRPV4 activation increased the expression of Langerin and led to increased intracellular calcium concentration in moLCs. Regarding the functionality of moLCs, we found that TRPV4 agonism had a mitigating effect on their inflammatory responses, since it decreased their cytokine production, and T cell activating capability. As TRPV4 has emerged as a potential therapeutic target in dermatological conditions, it is important to highlight LCs as a novel target of these therapies.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Langerhans sejt
Dendritikus sejt
Immunológia
Természetes immunitás
Megjelenés:Journal Of Investigative Dermatology. - 143 : 5 (2023), p. 801-811.e10. -
További szerzők:Pénzes Zsófia (1992-) (klinikai laboratóriumi kutató) Horváth Dorottya (1994-) (molekuláris biológus) Gyetvai Ágnes Bácsi Attila (1967-) (immunológus) Kis Gréta (1979-) (környezetkutató) Németh Ákos (1984-) (gyógyszer-vegyészmérnök, közgazdász) Arany József (1990-) (klinikai laboratóriumi kutató, vegyész) Oláh Attila (1984-) (élettanász) Lisztes Erika (1986-) (élettanász) Tóth István Balázs (1978-) (élettanász) Bíró Tamás (1968-) (élettanász) Szöllősi Attila Gábor (1982-) (élettanász)
Pályázati támogatás:125053
OTKA
128034
OTKA
134235
OTKA
GINOP-2.3.2-15-2016-00015
GINOP
GINOP-2.3.3-15-2016-00020
GINOP
EFOP-3.6.3-VEKOP-16-2017-00009
EFOP
MTA-DE
MTA
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM116425
Első szerző:Arany József (klinikai laboratóriumi kutató, vegyész)
Cím:Adenosine receptors are novel regulators of human sebocyte biology / Arany J., Ádám D., Cseszlai M., Nyitrai T., Zouboulis C. C., Oláh A.
Dátum:2023
ISSN:0022-202X 1523-1747
Megjegyzések:We have previously shown that (-)-cannabidiol, a non-psychotropic phytocannabinoid, exerted complex anti-acne effects, some of which were found to be mediated by the A2A adenosine receptor. Thus, in the current study, we aimed to investigate the expression and functional role of adenosine receptors on human SZ95 sebocytes. First, besides confirming the expression of A2A receptor, we showed that A1 and A2B adenosine receptors were also expressed in human sebocytes (Q-PCR, western blot), whereas expression of A3 was found to be around detection limit (Q-PCR). Next, by using non-cytotoxic concentrations (MTT-assay) of selective modulators of A2A and A2B receptors, we found that administration of the A2B agonist BAY 60-6583 led to a small, but significant increase in the basal, homeostatic sebaceous lipogenesis, while the A2B antagonist alloxazine reduced the lipid synthesis (24- and 48-hour treatments; Nile Red). Interestingly, administration of ZM 241385 (an A2A antagonist that can also block A2B receptor at higher concentrations) resulted in a concentration-dependent decrease of the lipid synthesis in course of 24-hr treatments, but did not influence lipogenesis in case of longer (48-hr) experiments (Nile Red). Importantly, the A2A agonist CGS 21680 slightly, but significantly decreased basal sebaceous lipogenesis (24- and 48-hr treatments; Nile Red), and could also suppress the lipogenic effect of the "acne-mimicking" inflammatory lipid mediator arachidonic acid (48-hr treatments; Nile Red). Last, but not least, our preliminary data suggest that activation of A2A, but, intriguingly, not of A2B, receptor is efficient in suppressing the Toll-like receptor 4 activator lipopolysaccharide-induced pro-inflammatory response as well (Q-PCR). Taken together, our data indicate that several adenosine receptors are expressed on human sebocytes. These receptors differentially influence sebocyte biology, and activation of A2A receptor appears to exert promising anti-acne effects in our in vitro model systems.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idézhető absztrakt
folyóiratcikk
sebocyte
acne
adenosine receptor
sebaceous lipogenesis
Megjelenés:Journal Of Investigative Dermatology. - 143 : Suppl_11 (2023), p. S355. -
További szerzők:Ádám Dorottya (1991-) (molekuláris biológus) Cseszlai M. Nyitrai Tamara (1999-) (molekuláris biológus) Zouboulis, Christos C. (1960-) (bőrgyógyász) Oláh Attila (1984-) (élettanász)
Pályázati támogatás:EFOP-3.6.3-VEKOP-16-2017-00009
EFOP
EFOP-3.6.1-16-2016-00022
EFOP
János Bolyai Research Scholarship
MTA
134235
OTKA
ÚNKP-23-5-DE-477
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM116427
Első szerző:Tóth Kinga Fanni (molekuláris biológus, élettanász)
Cím:Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses their endothelin release / Tóth K. F., Ádám D., Arany J., Ramirez Y. A., Bíró T., Drake J. I., O'Mahony A., Szöllősi A. G., Kilic A., Soeberdt M., Abels C., Oláh A.
Dátum:2023
ISSN:0022-202X 1523-1747
Megjegyzések:Pathological activity Toll-like receptor (TLR)-3 plays an important role in the pathogenesis of pruritic dermatoses and in the development of itch. Fluoxetine is a safe antidepressant with remarkable anti-inflammatory actions in various systems, including the skin. Thus, we aimed to investigate the effects of fluoxetine in a TLR3-activator induced inflammatory model by using immortalized (HaCaT) as well as primary human epidermal keratinocytes. When applied at a non-cytotoxic concentration (MTT-assay, CyQUANT-assay), fluoxetine significantly suppressed polyinosinic-polycytidylic acid (p(I:C))-induced expression and release of several proinflammatory cytokines, and it decreased the release of the itch mediator endothelins (Q-PCR, cytokine array, ELISA). Fluoxetine did not interfere with the p(I:C)-induced activation of the p38 MAPK cascade, and did not inhibit phosphorylation (and hence inactivation) of IkBa, an important inhibitor of the NF-kB pathway (western blot). Moreover, co-administration of fluoxetine failed to significantly suppress p(I:C)-induced elevation ofmitochondrial ROS production (MitoSOX Red). Instead, the anti-inflammatory effects of fluoxetine were most likely mediated via the inhibition of the phosphoinositide 3-kinase (PI3K)-pathway (unbiased activity profiling). Importantly, the PI3K-inhibitor GDC0941 fully mimicked the effects of fluoxetine. Although fluoxetine was found to be able to occupy the binding site of GDC0941 (in silico molecular docking), and to exert direct inhibitory effect on PI3K, it exhibited much lower potency and efficacy as compared to GDC0941 (cell-free PI3K activity assay). Collectively, our findings demonstrate that fluoxetine exerts potent anti-inflammatory effects, and suppresses the release of the endogenous itch mediator endothelins in human keratinocytes, most likely via indirect inhibition of PI3K. Thus, clinical studies are encouraged to explore whether the currently reported beneficial effects translate in vivo following its topical administration in inflammatory and pruritic dermatoses. Supported by: NRDIO (125055, 134235, 134993, GINOP-2.3.2-15-2016-00015, GINOP-2.3.3-15-2016-00020, EFOP-3.6.3-VEKOP-16-2017-00009); János Bolyai Research Scholarship; ÚNKP-23-5-DE-477; "Deutscher Akademischer Austauschdienst" (DAAD); Dr. AugustWolff GmbH & Co. KG Arzneimittel.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idézhető absztrakt
folyóiratcikk
fluoxetine
itch
inflammation
skin
keratinocyte
endothelin
Toll-like receptor 3
Megjelenés:Journal Of Investigative Dermatology. - 143 : 11 (2023), p. S361. -
További szerzők:Ádám Dorottya (1991-) (molekuláris biológus) Arany József (1990-) (klinikai laboratóriumi kutató, vegyész) Ramirez, Yesid A. Bíró Tamás (1968-) (élettanász) (absztraktok) Drake, Jennifer I. O'Mahony, Alison Szöllősi Attila Gábor (1982-) (élettanász) Kilic, Ana Soeberdt, Michael Abels, Christoph Oláh Attila (1984-) (élettanász)
Pályázati támogatás:125055
OTKA
134235
OTKA
134993
OTKA
GINOP-2.3.2-15-2016-00015
GINOP
GINOP-2.3.3-15-2016-00020
GINOP
EFOP-3.6.3-VEKOP-16-2017-00009
EFOP
János Bolyai Research Scholarship
MTA
ÚNKP-23-5-DE-477
Egyéb
Deutscher Akademischer Austauschdienst
Egyéb
Dr. AugustWolff GmbH & Co. KG Arzneimittel
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM115844
Első szerző:Tóth Kinga Fanni (molekuláris biológus, élettanász)
Cím:Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses endothelin release via inhibiting PI3K / Tóth K., Ádám D., Arany J., Ramirez Y. A., Bíró T., Drake J. I., O'Mahony A., Szöllösi A. G., Kilic A., Soeberdt M., Abels C., Oláh A.
Dátum:2023
ISSN:0022-202X 1523-1747
Megjegyzések:Fluoxetine (FX) is a safe antidepressant belonging to the group of selective serotonin reuptake inhibitors. It exhibits remarkable anti-inflammatory activity in various systems; thus, we aimed to investigate its biological effects on immortalized (HaCaT) and primary human epidermal keratinocytes. We found that, when applied at its highest non-cytotoxic concentration (14 mM), FX significantly suppressed the Toll-like receptor 3 activator polyinosinicpolycytidylic acid (p(I:C))-induced expression (Q-PCR: interleukin [IL]-1a, IL-1b, and IL-8) and release (cytokine array and ELISA: IL-8) of several pro-inflammatory cytokines, and it decreased the release of the itch mediator endothelins as well. Surprisingly, unbiased activity profiling revealed that the effects of FX (4.7 and 14 mM) did not resemble the effects of different doses of serotonin, but were rather similar to the effects of the phosphoinositide 3-kinase (PI3K) inhibitor GDC0941 (370 nM). In addition, GDC0941 mimicked the effects of FX in our experimental models, and in silico docking analysis revealed that FX may be able to occupy the same binding site on PI3K isoenzymes as GDC0941. Finally, we found that FX was indeed able to directly suppress activity of PI3K (cell-free PI3K activity assay). Collectively, our findings demonstrate that FX (14 mM) exerts potent anti-inflammatory effects, and suppresses the release of the endogenous itch mediator endothelins in human keratinocytes, most likely via the inhibition of PI3K. Thus, our data highlight the possibility of dermatological repositioning of FX to treat various inflammatory and pruritic dermatoses.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idézhető absztrakt
folyóiratcikk
fluoxetine
keratinocyte
itch
inflammation
Megjelenés:Journal Of Investigative Dermatology. - 143 : 5 (2023), p. S126. -
További szerzők:Ádám Dorottya (1991-) (molekuláris biológus) Arany József (1990-) (klinikai laboratóriumi kutató, vegyész) Ramirez, Yesid A. Bíró Tamás (1968-) (élettanász) (absztraktok) Drake, Jennifer I. O'Mahony, Alison Szöllősi Attila Gábor (1982-) (élettanász) Kilic, Ana Soeberdt, Michael Abels, Christoph Oláh Attila (1984-) (élettanász)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM082876
035-os BibID:(WOS)000485661500602
Első szerző:Tóth Kinga Fanni (molekuláris biológus, élettanász)
Cím:The putative tribbles homolog 3 (TRIB3) activator honokiol suppresses lipogenesis, and exerts anti-proliferative as well as anti-inflammatory effects on human sebocytes / Tóth K., Ádám D., Arany J., Faragó P., Arbiser J. L., Zouboulis C. C., Bíró T., Oláh A.
Dátum:2019
Megjegyzések:We have previously shown that cannabidiol (CBD) exerts complex anti-acne effects in vitro, and in vivo efficiency of topically administered CBD in moderate to severe acne is currently being assessed in a phase II clinical trial (ID at clinicaltrials.gov: NCT03573518). We have also demonstrated that anti-acne effects of CBD were at least in part mediated by the activation/upregulation of tribbles homolog 3 (TRIB3). Thus, here, we aimed to assess the effects of the plantderived TRIB3-activator honokiol (HNK) on human SZ95 sebocytes. We showed that, up to 20 uM, HNK did not impair viability (24/48 hrs; MTT-assay), but concentration-dependently decreased sebaceous lipogenesis (SLG) (24/48 hrs; Nile Red). To explore its putative anti-acne potential, we further assessed the effects of HNK on arachidonic acid (AA)-induced enhanced, acne-mimicking SLG. Importantly, non-cytotoxic HNK concentrations suppressed the lipogenic action of AA (24/48 hrs; Nile Red), and exerted significant anti-proliferative actions (72 hrs; CyQUANT-assay). Moreover, HNK was able to suppress the lipopolysaccharide-induced proinflammatory response of human sebocytes, as monitored by the expression (interleukin [IL]-1a, IL-1b, IL-6, IL-8, and tumor necrosis factor-a) and release (IL-8) of pro-inflammatory cytokines (3 hrs; Q-PCR and ELISA). Collectively, our data demonstrate that HNK exhibits complex anti-acne effects in vitro. These findings may therefore encourage the systematic exploration of topically applied HNK in the clinical management of acne.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idézhető absztrakt
folyóiratcikk
acne
honokiol
sebaceous lipid synthesis
inflammation
TRIB3
sebocyte
Megjelenés:Journal of Investigative Dermatology. - 139 : 9S (2019), p. S319. -
További szerzők:Ádám Dorottya (1991-) (molekuláris biológus) Arany József (1990-) (klinikai laboratóriumi kutató, vegyész) Faragó Péter Arbiser, J. L. Zouboulis, Christos C. (1960-) (bőrgyógyász) Bíró Tamás (1968-) (élettanász) (absztraktok) Oláh Attila (1984-) (élettanász)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1